title: [Diabetic asymmetric proximal neuropathy].
abstract: OBJECTIVE
  To study the prevalence, clinical features and treatment of diabetic asymmetric proximal neuropathy (DAPN).
  
  
  METHODS
  Four hundred and forty-five patients with diabetes mellitus (DM), 257 women and 188 men, mean age 47.6±0.5 years, including 163 patients with DM type I and 282 with DM type II, were examined.
  
  
  CONCLUSIONS
  Distal symmetric sensory motor polyneuropathy was found in 62% of the patients, autonomic neuropathy in 25.6%, somatic mononeuropathy in 28.5%, DAPN in 7.9%. DAPN was more frequent in patients with DM type II (9.6), with poor control of glycemia and DM duration more than 5 years. Pain and paresthesia in a zone of innervation of several roots and nerves, amyotrophy that spread beyond the definite myotome were key symptoms of DAPN. The efficacy of double therapy of neuropathic pain (pregabalin and duloxetine) and vitamin B complex was shown. A role of glucocorticoids and normal human immunoglobulin in treatment of DAPN is discussed.
authors.affiliation: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
authors.forename: S V
authors.initials: SV
authors.lastname: Kotov
authors.affiliation: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
authors.forename: I G
authors.initials: IG
authors.lastname: Rudakova
authors.affiliation: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
authors.forename: E V
authors.initials: EV
authors.lastname: Isakova
authors.affiliation: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
authors.forename: Yu A
authors.initials: YA
authors.lastname: Belova
authors.affiliation: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
authors.forename: T V
authors.initials: TV
authors.lastname: Volchenkova
authors.affiliation: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
authors.forename: M
authors.initials: M
authors.lastname: Khirbek
authors.affiliation: Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
authors.forename: G A
authors.initials: GA
authors.lastname: Stashuk
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000700:Analgesics / Q000627:therapeutic use; D001341:Autonomic Nervous System / Q000503:physiopathology; D001786:Blood Glucose; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000453:epidemiology*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000453:epidemiology*; D003929:Diabetic Neuropathies / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D000068736:Duloxetine Hydrochloride / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009437:Neuralgia / Q000175:diagnosis / Q000188:drug therapy; D000069583:Pregabalin / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000700:Analgesics; D001786:Blood Glucose; D000069583:Pregabalin; D000068736:Duloxetine Hydrochloride